NOX 0.00% 10.0¢ noxopharm limited

too right. Massive headline screams “FDA IND BREAKTHROUGH for...

  1. 508 Posts.
    lightbulb Created with Sketch. 236
    too right.
    Massive headline screams “FDA IND BREAKTHROUGH for Veyonda”

    the actual news: we’ve selected a CRO.

    I can’t stop laughing. My sides are actually splitting.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.